NUCLEAR
MOLECULAR TARGETNuclear factor erythroid 2-related factor 2 (human)
NUCLEAR (Nuclear factor erythroid 2-related factor 2 (human)) is targeted by 162 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NUCLEAR
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
Showing top 50 of 162 compounds. Use the BiohacksAI search to explore all NUCLEAR modulators.
About NUCLEAR as a Drug Target
NUCLEAR (Nuclear factor erythroid 2-related factor 2 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 162 compounds with documented NUCLEAR interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NUCLEAR inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.